Washington is currently home to 1777 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Seattle, Spokane, Tacoma and Vancouver. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Innovative Liver Elasticity, Attenuation, and Dispersion Ultrasound Study
NCT04012242
Recruiting
The objective of this study is: (1) to investigate the correlation of ultrasound parameters (SW speed, Dispersion slope, Attenuation value, Normalized Local Variance, Liver / Kidney Intensity Ratio) with the pathological parameters (fibrosis, intralobular inflammation, ballooning degeneration and steatosis); (2) to evaluate the diagnostic performance of SW speed for liver fibrosis, Dispersion slope for intralobular inflammation and Attenuation value for steatosis by comparison with the tissue di... Read More
Gender:
All
Ages:
20 years and above
Trial Updated:
02/06/2022
Locations: University of Washington, Seattle, Washington
Conditions: Nonalcoholic Steatohepatitis, Ultrasound, Elastography
Register for Updates
Treatment of Radiation and Cisplatin Induced Toxicities With Tempol
NCT03480971
Recruiting
A 10 week trial to assess the ability of Tempol to prevent and/or reduce toxicities associated with cisplatin and radiation treatment in head and neck cancer patients. Over the course of the 10 week trial, mucositis, nephrotoxicity, and ototoxicity will be monitored and assessed.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/02/2022
Locations: Seattle Cancer Care Alliance, Seattle, Washington
Conditions: Mucositis, Nephrotoxicity, Ototoxicity
Register for Updates
NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection
NCT04452565
Recruiting
This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/31/2022
Locations: Coronavirus Research Institute-Testing Site, Kirkland, Washington
Conditions: Coronavirus Infection, Severe Acute Respiratory Infection, Severe Acute Respiratory Syndrome Coronavirus 2
Register for Updates
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
NCT05211856
Recruiting
The purpose of this study is to evaluate the efficacy and safety of acalabrutinib in combination with venetoclax and acalabrutinib in combination with venetoclax with and without obinutuzumab compared to chemoimmunotherapy in subjects with previously untreated CLL.
Gender:
All
Ages:
Between 18 years and 130 years
Trial Updated:
01/14/2022
Locations: Research Site, Seattle, Washington
Conditions: Chronic Lymphocytic Leukemia
Register for Updates
An Observational Study of Patients With Coronavirus Disease 2019
NCT04331886
Recruiting
This is an observational study of patients with COVID-19 designed to specifically address important clinical questions that remain incompletely answered for coronavirus disease 2019.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/14/2022
Locations: University of Washington, Seattle, Washington
Conditions: COVID-19, Coronavirus
Register for Updates
The EMPOWER Study: Endometriosis Diagnosis Using microRNA
NCT04598698
Recruiting
Endometriosis is a complex, heterogeneous disease that may present inconsistently across women. Using disease-specific biomarkers and advanced biostatistics, DotLab is developing a biomarker test to confirm the presence of endometriosis.This is a multi-center, prospective, observational, minimal risk study in women undergoing laparoscopy, laparotomy or other pelvic surgical procedure for endometriosis, infertility or another benign gynecological indication. Participants will undergo 2 study visi... Read More
Gender:
Female
Ages:
Between 18 years and 49 years
Trial Updated:
01/11/2022
Locations: Seattle Reproductive Medicine, Seattle, Washington
Conditions: Endometriosis
Register for Updates
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
NCT02675946
Recruiting
This is a multicenter, open-label study conducted in two phases: Phase 1 consisting of a CGX1321 Single Agent Dose Escalation Phase in solid tumors, CGX1321 Single Agent Dose Expansion Phase in GI tumors and Roll-over Cohort of CGX1321 and pembrolizumab in subjects who have progressed on single agent CGX1321 and Phase 1b consisting of CGX1321 in combination with pembrolizumab in colorectal tumors and CGX1321 in combination with encorafenib + cetuximab in BRAFV600E mutated colorectal tumors. Both... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/11/2022
Locations: Northwest Medical Specialists (QCCA), Tacoma, Washington
Conditions: Solid Tumors, GI Cancer
Register for Updates
Safety and Durability of Sirolimus for Treatment of LAM
NCT02432560
Recruiting
The MIDAS study aims to follow LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR inhibitors (sirolimus or everolimus) as part of their clinical care. Adult female TSC patients may also enroll, with or without lung cysts.
Gender:
Female
Ages:
18 years and above
Trial Updated:
01/11/2022
Locations: Swedish Medical Center, Seattle, Washington
Conditions: Lymphangioleiomyomatosis
Register for Updates
Prospective Evaluation and Comparison of Bilateral Synergy Implants and Bilateral PanOptix Implants
NCT05186298
Recruiting
The purpose of this study is to evaluate the AcrySof PanOptix Intraocular Lens (IOL) for binocular distance corrected near visual acuity (DCNVA) compared to TECNIS Synergy IOL. Presbyopia correcting diffractive intraocular implants (extended depth of focus, multifocal, and trifocal) provide cataract and refractive surgeons with an effective treatment means for allowing patients to experience increased spectacle independence post-cataract surgery.
Gender:
All
Ages:
22 years and above
Trial Updated:
01/10/2022
Locations: Northwest Eye Surgeons, Seattle, Washington
Conditions: Cataract
Register for Updates
Flicker App for Minimal Hepatic Encephalopathy
NCT04415294
Recruiting
There is a great unmet clinical need for improved screening for MHE in patients with cirrhosis. We will demonstrate that the Flicker-App can be used in clinic as well as at home by patients with cirrhosis to measure CFF, a proven screening test for MHE. We will optimize the protocol, software, and hardware of the Flicker-App to create a product appropriate for production and distribution to patients
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
01/07/2022
Locations: University of Washington Medical Center, Seattle, Washington
Conditions: Hepatic Encephalopathy
Register for Updates
Community-Engaged Options to Facilitate Opioid Reduction
NCT05098158
Recruiting
This study investigates how adults prescribed opioids for chronic noncancer pain respond to invitations to try non-opioid options of massage therapy, yoga therapy, chiropractic and physical therapies. Due to the COVID-19 pandemic, these options will be available via telehealth consultation visits using a computer or smartphone with internet connection. The investigators will measure effects on pain, pain-related symptoms, and opioid use over time using a single-group design.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/15/2021
Locations: Community Health Association of Spokane, Spokane, Washington
Conditions: Chronic Pain
Register for Updates
Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19
NCT04380870
Recruiting
The purpose of the study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19.
Gender:
All
Ages:
Between 18 years and 114 years
Trial Updated:
09/27/2021
Locations: Seattle Intstitute of East Asian Medicine, Seattle, Washington
Conditions: Coronavirus Infection
Register for Updates